Evidence map›Paper›PMID 42355854›Full record

ReviewJournal of clinical medicine2026

Motion Analysis Technologies for ACL Injury Prevention: From Laboratory Assessment to Field-Based Clinical Screening.

Abdulmajeed Alfayyadh

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Abdulmajeed AlfayyadhDepartment of Physical Therapy and Health Rehabilitation, College of Applied Medical Sciences, Jouf University, Sakaka 72388, Saudi Arabia.ORCID 0009-0004-7204-4472

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anterior cruciate ligament (ACL) injuries remain a leading cause of morbidity in athletic populations, with 70-80% occurring through non-contact mechanisms driven by biomechanical risk factors including knee valgus (>10°), low knee flexion (<30°), tibial internal rotation (>20°), and loading asymmetry (>15°), yet implementation of evidence-based neuromuscular training (which reduces injury risk by 50-70%) remains limited due to barriers in identifying at-risk individuals through accessible field-based screening. This narrative review synthesizes motion analysis technologies spanning laboratory-based optical systems (marker-based), wearable inertial measurement units (IMUs), computer vision and marker-less pose estimation, force plate and pressure-sensitive insole systems, and integrated drone-based field assessment platforms to address this critical gap. We present a three-tier clinical screening framework that progresses from basic anthropometric and single-plane video analysis to multi-modal biomechanical assessment using real-time kinematic feedback. As an illustrative example of emerging field-deployable technology, an integrated drone-based motion capture and smart insole system combining 4K video capture, AI-driven 3D motion reconstruction, and plantar pressure mapping is described to demonstrate how laboratory-quality biomechanical assessment can be achieved in ecologically valid field settings. This evidence-based review addresses current gaps between laboratory research and practical field deployment, with emphasis on cost-effectiveness, accessibility, and clinical utility for ACL injury prevention in diverse sporting environments.

Indexed as

ACL injury preventionbiomechanical screeningdrone systemsfield-based assessmentmachine learningmarker-less pose estimationmotion capturereturn-to-sportwearable sensors

Identifiers

PMID42355854
PMCPMC13301095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.